시장 개관

The global gastrointestinal endoscopy market, 가치가 있는 $13.40 10억 2021, 도달할 것으로 예상된다 $25.75 10억 단위로 2031, CAGR로 6.24% 예측 기간 동안 2022-2031. This growth is driven by factors such as the increasing prevalence of gastrointestinal diseases, a preference for minimally invasive surgeries, growing demand for capsule endoscopy, the shift from reusable to disposable endoscopes, and technological advancements in robot-assisted endoscopes and AI-based devices.

The market is currently in a developed phase, with opportunities arising from the demand for single-use endoscopes, integration of robotics and AI, and the popularity of capsule endoscopy. Key trends include the shift towards robot-assisted surgery, the development of single-use endoscopes, the rise in demand for minimally invasive procedures, and an increase in product launches by market players.

Factors driving market growth include the rising prevalence of chronic gastrointestinal diseases, particularly gastrointestinal cancers, and the adoption of advanced technologies like wireless capsule endoscopy and disposable endoscopes. Disposable endoscopes offer advantages such as infection prevention and cost-effectiveness compared to reusable counterparts, leading to their development by major players.

On the demand side, drivers for the market include the increasing prevalence of chronic gastrointestinal diseases, the adoption of disposable endoscopes, the preference for minimally invasive procedures, and the shift towards wireless capsule endoscopy. Limitations include a shortage of skilled healthcare professionals and the lack of reimbursement frameworks.

시장 세분화

시장은 다양한 요인에 따라 분류됩니다., 유형 포함, 최종 사용자, 및 지역.

유형별 세분화
Gastrointestinal Endoscopes and Endoscopic Systems – Capsule Endoscopes, Gastrointestinal Videoscopes, and Visualization Systems
Gastrointestinal Endotherapy – Ultrasound Endoscopes, Balloon Dilators, Gastrointestinal Stents, Biopsy Devices, Retrieval Devices, ERCP Devices, Hemostasis Devices, 다른 사람

최종 사용자별 세분화
병원
Ambulatory Surgery Centers
기타

지역별 세분화
북아메리카 – 우리를. 캐나다
유럽 – 독일, 프랑스, 영국, 이탈리아, 스페인, 및 유럽 나머지 지역
아시아 태평양 – 일본, 중국, 인도, 호주와 뉴질랜드, 대한민국, 및 기타 아시아 태평양 지역
라틴 아메리카 – 아르헨티나, 브라질, 멕시코, 및 나머지 라틴 아메리카
중동 및 아프리카 – K.S.A., U.A.E., 및 기타 중동 및 아프리카

The gastrointestinal endoscopy market is expected to be predominantly led by the gastrointestinal endoscopes and endoscopic systems segment. This global market is further divided into two main segments: gastrointestinal endoscopes and endoscopic systems, and gastrointestinal endotherapy. The former consists of endoscopic devices used for diagnostic purposes, while the latter includes surgical instruments and devices used for surgical procedures to treat detected indications. 현재 2021, the endotherapy segment holds a larger share in the global gastrointestinal endoscopy market, 가치가 있는 $7,236 백만, compared to the endoscopes and endoscopic systems segment, 가치가 있는 $6,172 백만.

하지만, the endoscopes and endoscopic systems segment is projected to grow at a CAGR of 7.15% 예측 기간 동안 2022-2031. This growth can be attributed to the increasing awareness among the population regarding the screening of chronic gastrointestinal diseases, especially gastrointestinal cancers like colorectal cancer.

The gastrointestinal endoscopes and endoscopic systems segment can be further categorized into gastrointestinal videoscopes, capsule endoscopes, and visualization systems. The introduction of gastrointestinal videoscopes, along with visualization systems such as light sources, cameras, monitors, 다른 사람, has significantly transformed the landscape of the gastrointestinal endoscopy market. Previously, rigid and fiberoptic endoscopes were the primary options for diagnosing and treating gastrointestinal indications. 하지만, their usage has diminished with the advent of gastrointestinal videoscopes. Major players offering various gastrointestinal videoscopes and visualization systems include Olympus Corporation, HOYA Corporation, and FUJIFILM Holdings Corporation, 무엇보다도.

In terms of end users, the hospital segment dominates the global gastrointestinal endoscopy market. Hospitals account for a major share due to the uptake of endoscopic procedures by private hospitals. Given the cost-intensive nature of gastrointestinal endoscopy and associated accessories, as well as the steep learning curve for surgeons, these minimally invasive procedures are mostly affordable and accessible to high-end multispecialty private hospitals and clinics. Public healthcare centers often face financial constraints in this regard. 하지만, there is a shift toward reducing healthcare costs by moving inpatient procedures to outpatient centers, which is gradually changing this trend.

North America stands as the dominant region in the gastrointestinal endoscopy market, owing to superior healthcare systems, advanced infrastructure, high adoption rates of new technology, increased demand for minimally invasive surgeries, and the high efficacy and low relapse rate associated with endoscopic procedures. ~ 안에 2021, 북미가 가장 큰 비중을 차지 38.97% in the global market, primarily due to the presence of major players and technological advancements. Major U.S.-based players in the gastrointestinal endoscopy market include Medtronic plc, 보스턴 사이언티픽 코퍼레이션, Cook Group Inc, and Teleflex Incorporated.

경쟁 구도

The selection of the profiled companies was based on inputs obtained from primary experts, as well as an analysis of their company coverage, 제품 포트폴리오, 그리고 시장 침투.

Key companies profiled in this report include Boston Scientific Corporation, 메드트로닉 PLC, KARL STORZ SE & 공동. 킬로그램, Ambu A/S, Teleflex Incorporated, HOYA Corporation, Olympus Corporation, 후지필름 홀딩스 주식회사, Cook Group Inc, SonoScape Medical Corp., EndoMed Systems GmbH, CapsoVision, 주식회사, HuiZhou Xzing Technology Co., (주), Endogene Ltd., Envaste Limited.

최근 산업 발전

5월 2022, Limaca-Medical obtained breakthrough device recognition from the FDA for its Precision-GI endoscopic ultrasound biopsy device.

2월 2022, Ambu A/S received FDA approval for its Ambu aScope Gastro and Ambu aBox 2.

11 월 2021, Medtronic plc received 510(케이) clearance from the FDA for its Pillcam Small Bowel 3 체계, enabling remote endoscopy procedures.

8 월 2021, Ambu received CE mark approval for its Ambu aScope Duodeno, which is a disposable duodenoscope.

주요 질문에 대한 답변

What are the primary drivers, limitations, and opportunities for the global gastrointestinal endoscopy market?

What are some key strategies implemented by major players in the market?

Who are the main key players in the global gastrointestinal endoscopy market?

How has the COVID-19 pandemic impacted the global gastrointestinal endoscopy market, and what is the expected duration of this impact on the market?

Why is the global gastrointestinal endoscopy market transitioning from reusable endoscopes to disposable ones?

Why is the global gastrointestinal endoscopy market shifting from open surgeries to robot-assisted surgeries?

What are the significant trends in the field of global gastrointestinal endoscopy, and how will they affect the market in the future?

What are the ongoing clinical trials in the global gastrointestinal endoscopy market?